Hansoh Bio is the US R&D subsidiary of Hansoh Pharma, a major publicly traded biopharmaceutical company with significant global revenue and reach. The project demonstrates exceptional Real-World Utility and Traction due to its established status in oncology and CNS therapeutics. However, the submission quality is notably poor (e.g., exaggerated claims like 'most people have used my product', informal username), which negatively impacts the Quality Factors and Response Quality score. Despite the low-effort submission, the verifiable scale of the parent entity places this project in the highest tier of validation.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline